RGD-conjugated paclitaxel and microRNA-34a loaded liposomes target and inhibit A549 cells
|更新时间:2025-01-15
|
RGD-conjugated paclitaxel and microRNA-34a loaded liposomes target and inhibit A549 cells
Journal of Army Medical UniversityVol. 36, Issue 11, Pages: 1183-1186(2014)
作者机构:
新乡医学院第一附属医院呼吸科
作者简介:
基金信息:
DOI:
CLC:R73-361;R734.2;R979.1
Published:2014,
Published Online:15 June 2014,
稿件说明:
移动端阅览
ZHAO XIN. RGD-conjugated paclitaxel and microRNA-34a loaded liposomes target and inhibit A549 cells. [J]. Journal of army medical university, 2014, 36(11): 1183-1186.
DOI:
ZHAO XIN. RGD-conjugated paclitaxel and microRNA-34a loaded liposomes target and inhibit A549 cells. [J]. Journal of army medical university, 2014, 36(11): 1183-1186.DOI:
RGD-conjugated paclitaxel and microRNA-34a loaded liposomes target and inhibit A549 cells
Objective To prepare arginine-glycine-aspartic acid (RGD)-conjugated paclitaxel (PTX) and microRNA-34a co-loaded liposome (RGDmiLPs-34a/PTX)
and to evaluate their properties
and targeting inhibitory effects in A549 cells. Methods The liposomes RGDmiLPs-34a/PTX were prepared by thin film hydration. The particle size
zeta potential and entrapment efficiency were evaluated. The efficiency of cellular uptake and tumor spheroids penetration of RGDLP and LP on A549 cells
in vitro
was evaluated by cellular uptaking test and cofocal laser scanning microscopy. The anti-proliferation efficiency of RGDmiLPs-34a/PTX to A549 cells was evaluated by MTT assay. Tumor spheroids were used to evaluate anti-tumor ability of RGDmiLPs-34a/PTX. Results The particle diameter of the RGDmiLPs-34a/PTX was 125.0±11.8 nm with a zeta potential of 21.00±4.85 mV. The entrapment efficiency of PTX and microRNA-34a were 81.5% and 94.6% respectively. The result of cellular uptaking test demonstrated that RGDLP were uptaken by A549 cells by 2.6 times higher than LP (
P
<
0.01). MTT assay confirmed RGDmiLPs-34a/PTX had stronger inhibitory effect to A549 cells than miLPs-34a/PTX
RGDmiLPs-34a and RGDLP-PTX. The tumor spheroid was inhibited by 81%
77%
64% and 37% respectively when treated by miLPs-34a/PTX
RGDmiLPs-34a
RGDLP-PTX and RGDmiLPs-34a/PTX
with the latest having the strongest inhibitory effect (
P
<
0.01). Conclusion RGD-conjugated PTX and microRNA-34a co-loaded liposomes RGDmiLPs-34a/PTX are well targeting to and exerting inhibitory effect on lung cancer cells
and they are a potential delivery system for the treatment of lung cancer.
关键词
整合素受体microRNA-34a紫杉醇脂质体肺癌
Keywords
integrin receptormicroRNA-34apaclitaxelliposomelung cancer
Effect of RGD-modified paclitaxel and microRNA-34a co-loaded liposome on inhibiting tumor growth in A549-bearing nude mice
Effect of 3-bromopyruvate combined with cisplatin on inhibiting growth of lung cancer A549 cells
Related Author
Zhao Xin
Zhang Jian
ZHAO Binyu
ZHANG Junlei
WANG Jiaqi
RUAN Yan
ZHANG Yue
LIU Lianlian
Related Institution
Department of Respiratory Diseases, Pediatric Intensive Care Unit, First Affiliated Hospital, Xinxiang Medical University
Department of Physiology, 2Department of Histology and Embryology, 3Teaching Experiment Center, College of Basic Medical Sciences, Army Medical University (Third Military Medical University)
Department of Ophthalmology, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Center of Clinical Laboratory, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education, Defense Key Disciplines Lab of Novel Micro-Nano Devices and System Technology, Chongqing University